Copyright Reports & Markets. All rights reserved.

Global Cell Immortalization Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Cell Immortalization Market Size 2017-2028
    • 2.1.2 Cell Immortalization Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Cell Immortalization Segment by Type
    • 2.2.1 Stem Cell Therapy
    • 2.2.2 Cell Transplantation
    • 2.2.3 Drug Transport
    • 2.2.4 Others
  • 2.3 Cell Immortalization Market Size by Type
    • 2.3.1 Cell Immortalization Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Cell Immortalization Market Size Market Share by Type (2017-2022)
  • 2.4 Cell Immortalization Segment by Application
    • 2.4.1 Pharmaceutical and Biopharmaceutical Company
    • 2.4.2 Research Laboratory
    • 2.4.3 Hospital
    • 2.4.4 Other
  • 2.5 Cell Immortalization Market Size by Application
    • 2.5.1 Cell Immortalization Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Cell Immortalization Market Size Market Share by Application (2017-2022)

3 Cell Immortalization Market Size by Player

  • 3.1 Cell Immortalization Market Size Market Share by Players
    • 3.1.1 Global Cell Immortalization Revenue by Players (2020-2022)
    • 3.1.2 Global Cell Immortalization Revenue Market Share by Players (2020-2022)
  • 3.2 Global Cell Immortalization Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Cell Immortalization by Regions

  • 4.1 Cell Immortalization Market Size by Regions (2017-2022)
  • 4.2 Americas Cell Immortalization Market Size Growth (2017-2022)
  • 4.3 APAC Cell Immortalization Market Size Growth (2017-2022)
  • 4.4 Europe Cell Immortalization Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Cell Immortalization Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Cell Immortalization Market Size by Country (2017-2022)
  • 5.2 Americas Cell Immortalization Market Size by Type (2017-2022)
  • 5.3 Americas Cell Immortalization Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Cell Immortalization Market Size by Region (2017-2022)
  • 6.2 APAC Cell Immortalization Market Size by Type (2017-2022)
  • 6.3 APAC Cell Immortalization Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Cell Immortalization by Country (2017-2022)
  • 7.2 Europe Cell Immortalization Market Size by Type (2017-2022)
  • 7.3 Europe Cell Immortalization Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Cell Immortalization by Region (2017-2022)
  • 8.2 Middle East & Africa Cell Immortalization Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Cell Immortalization Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Cell Immortalization Market Forecast

  • 10.1 Global Cell Immortalization Forecast by Regions (2023-2028)
    • 10.1.1 Global Cell Immortalization Forecast by Regions (2023-2028)
    • 10.1.2 Americas Cell Immortalization Forecast
    • 10.1.3 APAC Cell Immortalization Forecast
    • 10.1.4 Europe Cell Immortalization Forecast
    • 10.1.5 Middle East & Africa Cell Immortalization Forecast
  • 10.2 Americas Cell Immortalization Forecast by Country (2023-2028)
    • 10.2.1 United States Cell Immortalization Market Forecast
    • 10.2.2 Canada Cell Immortalization Market Forecast
    • 10.2.3 Mexico Cell Immortalization Market Forecast
    • 10.2.4 Brazil Cell Immortalization Market Forecast
  • 10.3 APAC Cell Immortalization Forecast by Region (2023-2028)
    • 10.3.1 China Cell Immortalization Market Forecast
    • 10.3.2 Japan Cell Immortalization Market Forecast
    • 10.3.3 Korea Cell Immortalization Market Forecast
    • 10.3.4 Southeast Asia Cell Immortalization Market Forecast
    • 10.3.5 India Cell Immortalization Market Forecast
    • 10.3.6 Australia Cell Immortalization Market Forecast
  • 10.4 Europe Cell Immortalization Forecast by Country (2023-2028)
    • 10.4.1 Germany Cell Immortalization Market Forecast
    • 10.4.2 France Cell Immortalization Market Forecast
    • 10.4.3 UK Cell Immortalization Market Forecast
    • 10.4.4 Italy Cell Immortalization Market Forecast
    • 10.4.5 Russia Cell Immortalization Market Forecast
  • 10.5 Middle East & Africa Cell Immortalization Forecast by Region (2023-2028)
    • 10.5.1 Egypt Cell Immortalization Market Forecast
    • 10.5.2 South Africa Cell Immortalization Market Forecast
    • 10.5.3 Israel Cell Immortalization Market Forecast
    • 10.5.4 Turkey Cell Immortalization Market Forecast
    • 10.5.5 GCC Countries Cell Immortalization Market Forecast
  • 10.6 Global Cell Immortalization Forecast by Type (2023-2028)
  • 10.7 Global Cell Immortalization Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 GeneCopoeia
    • 11.1.1 GeneCopoeia Company Information
    • 11.1.2 GeneCopoeia Cell Immortalization Product Offered
    • 11.1.3 GeneCopoeia Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 GeneCopoeia Main Business Overview
    • 11.1.5 GeneCopoeia Latest Developments
  • 11.2 Lonza
    • 11.2.1 Lonza Company Information
    • 11.2.2 Lonza Cell Immortalization Product Offered
    • 11.2.3 Lonza Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Lonza Main Business Overview
    • 11.2.5 Lonza Latest Developments
  • 11.3 Thermo Fisher Scientific
    • 11.3.1 Thermo Fisher Scientific Company Information
    • 11.3.2 Thermo Fisher Scientific Cell Immortalization Product Offered
    • 11.3.3 Thermo Fisher Scientific Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Thermo Fisher Scientific Main Business Overview
    • 11.3.5 Thermo Fisher Scientific Latest Developments
  • 11.4 JSR
    • 11.4.1 JSR Company Information
    • 11.4.2 JSR Cell Immortalization Product Offered
    • 11.4.3 JSR Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 JSR Main Business Overview
    • 11.4.5 JSR Latest Developments
  • 11.5 Valneva
    • 11.5.1 Valneva Company Information
    • 11.5.2 Valneva Cell Immortalization Product Offered
    • 11.5.3 Valneva Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Valneva Main Business Overview
    • 11.5.5 Valneva Latest Developments
  • 11.6 Sartorius
    • 11.6.1 Sartorius Company Information
    • 11.6.2 Sartorius Cell Immortalization Product Offered
    • 11.6.3 Sartorius Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Sartorius Main Business Overview
    • 11.6.5 Sartorius Latest Developments
  • 11.7 Merck
    • 11.7.1 Merck Company Information
    • 11.7.2 Merck Cell Immortalization Product Offered
    • 11.7.3 Merck Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Merck Main Business Overview
    • 11.7.5 Merck Latest Developments
  • 11.8 Applied Biological Materials Inc.
    • 11.8.1 Applied Biological Materials Inc. Company Information
    • 11.8.2 Applied Biological Materials Inc. Cell Immortalization Product Offered
    • 11.8.3 Applied Biological Materials Inc. Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Applied Biological Materials Inc. Main Business Overview
    • 11.8.5 Applied Biological Materials Inc. Latest Developments
  • 11.9 InSCREENeX GmbH
    • 11.9.1 InSCREENeX GmbH Company Information
    • 11.9.2 InSCREENeX GmbH Cell Immortalization Product Offered
    • 11.9.3 InSCREENeX GmbH Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 InSCREENeX GmbH Main Business Overview
    • 11.9.5 InSCREENeX GmbH Latest Developments
  • 11.10 BioCat GmbH
    • 11.10.1 BioCat GmbH Company Information
    • 11.10.2 BioCat GmbH Cell Immortalization Product Offered
    • 11.10.3 BioCat GmbH Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 BioCat GmbH Main Business Overview
    • 11.10.5 BioCat GmbH Latest Developments
  • 11.11 Creative Biolabs
    • 11.11.1 Creative Biolabs Company Information
    • 11.11.2 Creative Biolabs Cell Immortalization Product Offered
    • 11.11.3 Creative Biolabs Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Creative Biolabs Main Business Overview
    • 11.11.5 Creative Biolabs Latest Developments
  • 11.12 GenScript
    • 11.12.1 GenScript Company Information
    • 11.12.2 GenScript Cell Immortalization Product Offered
    • 11.12.3 GenScript Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 GenScript Main Business Overview
    • 11.12.5 GenScript Latest Developments
  • 11.13 Nucleus Biotech
    • 11.13.1 Nucleus Biotech Company Information
    • 11.13.2 Nucleus Biotech Cell Immortalization Product Offered
    • 11.13.3 Nucleus Biotech Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Nucleus Biotech Main Business Overview
    • 11.13.5 Nucleus Biotech Latest Developments
  • 11.14 ALSTEM
    • 11.14.1 ALSTEM Company Information
    • 11.14.2 ALSTEM Cell Immortalization Product Offered
    • 11.14.3 ALSTEM Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 ALSTEM Main Business Overview
    • 11.14.5 ALSTEM Latest Developments
  • 11.15 Maxanim
    • 11.15.1 Maxanim Company Information
    • 11.15.2 Maxanim Cell Immortalization Product Offered
    • 11.15.3 Maxanim Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Maxanim Main Business Overview
    • 11.15.5 Maxanim Latest Developments
  • 11.16 Bio-REV Singapore
    • 11.16.1 Bio-REV Singapore Company Information
    • 11.16.2 Bio-REV Singapore Cell Immortalization Product Offered
    • 11.16.3 Bio-REV Singapore Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Bio-REV Singapore Main Business Overview
    • 11.16.5 Bio-REV Singapore Latest Developments
  • 11.17 MilliporeSigma
    • 11.17.1 MilliporeSigma Company Information
    • 11.17.2 MilliporeSigma Cell Immortalization Product Offered
    • 11.17.3 MilliporeSigma Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 MilliporeSigma Main Business Overview
    • 11.17.5 MilliporeSigma Latest Developments
  • 11.18 AcceGen
    • 11.18.1 AcceGen Company Information
    • 11.18.2 AcceGen Cell Immortalization Product Offered
    • 11.18.3 AcceGen Cell Immortalization Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 AcceGen Main Business Overview
    • 11.18.5 AcceGen Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Cell Immortalization will have significant change from previous year. According to our (LP Information) latest study, the global Cell Immortalization market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cell Immortalization market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Cell Immortalization market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Cell Immortalization market, reaching US$ million by the year 2028. As for the Europe Cell Immortalization landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Cell Immortalization players cover GeneCopoeia, Lonza, Thermo Fisher Scientific, and JSR, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Immortalization market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Stem Cell Therapy
Cell Transplantation
Drug Transport
Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pharmaceutical and Biopharmaceutical Company
Research Laboratory
Hospital
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GeneCopoeia
Lonza
Thermo Fisher Scientific
JSR
Valneva
Sartorius
Merck
Applied Biological Materials Inc.
InSCREENeX GmbH
BioCat GmbH
Creative Biolabs
GenScript
Nucleus Biotech
ALSTEM
Maxanim
Bio-REV Singapore
MilliporeSigma
AcceGen
Buy now